CTKB Cytek Biosciences, Inc.
$4.61▲ +1.77%
Healthcare
Other
After hours
$4.54▼ -1.57%
Sep 11, 6:19 PM ET
Volume 897.7K
Avg Volume (10D) 844.1K
Key Metrics & Fundamentals
Market Cap
$599.22M
P/E Ratio
–
Div Yield
–%
52W Range
3.28 - 6.18
% vs 50 MA
0.99%
% vs 200 MA
0.39%
RSI-14
50.0
MACD Histogram
-0.0200
Beta (1Y vs SPY)
0.98
Free Cash Flow
-$877,000
Gross Rev
$48.14M
Gross Profit
$28.34M
EBITDA
-$8.38M
COGS
$19.80M
Operating Exp
$39.74M
Operating Income
-$11.40M
EBIT
-$11.40M
Pretax Income
-$11.64M
Net Income
-$12.16M
EPS (Diluted)
-0.09
Price & Volume History
Loading chart…
Recent News
Cytek Biosciences, Sysmex Europe Collaborate to Deliver Clinical Flow Cytometry Workflows
MT Newswires · Sep 9, 2026 1:52 PM
Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry
GlobeNewswire · Sep 9, 2026 12:30 PM
Cytek’s (CTKB) Instruments Keep Selling While Losses Keep Growing
Insider Monkey · Sep 9, 2026 6:37 AM
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
GlobeNewswire · Sep 3, 2026 9:00 PM
Cytek Biosciences to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 1, 2026 8:05 PM
Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding
GlobeNewswire · Aug 21, 2026 8:35 PM
Cytek (CTKB) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 12, 2026 11:29 PM
Cytek Biosciences, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 6, 2026 12:30 PM
Cytek Biosciences Inc (CTKB) (Q2 2026) Earnings Call Highlights: Revenue Up 6% to $48. ...
GuruFocus.com · Aug 6, 2026 5:07 AM
Cytek Biosciences Q2 Earnings Call Highlights
MarketBeat · Aug 6, 2026 12:04 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See CTKB's money flow as a full page
Social Sentiment
No Reddit posts found for CTKB.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.